- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 317/18 - SulfonesSulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
Patent holdings for IPC class C07C 317/18
Total number of patents in this class: 140
10-year publication summary
|
7
|
7
|
14
|
12
|
7
|
10
|
6
|
7
|
6
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 260 |
15 |
| PRC-DeSoto International, Inc. | 565 |
8 |
| Duke University | 3103 |
5 |
| The University of North Carolina at Chapel Hill | 2062 |
5 |
| BASF SE | 21080 |
4 |
| ProLynx LLC | 53 |
4 |
| The University of British Columbia | 1524 |
4 |
| Boehringer Ingelheim International GmbH | 4648 |
3 |
| Kappa Bioscience AS | 45 |
3 |
| Provincial Health Services Authority | 188 |
3 |
| Translate bio, Inc. | 414 |
3 |
| Bristol-myers Squibb Company | 4848 |
2 |
| Merck Patent GmbH | 5756 |
2 |
| Sumitomo Chemical Company, Limited | 9095 |
2 |
| Board of Regents, The University of Texas System | 5917 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2205 |
2 |
| Central Glass Company, Limited | 1274 |
2 |
| Dalian University of Technology | 1538 |
2 |
| Reviva Pharmaceuticals, Inc. | 45 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 304 |
2 |
| Other owners | 65 |